Trials / Completed
CompletedNCT03853512
A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Skin to Recover After a Peeling in the External Genital Area of Women
Safety Assessment, Instrumental and Perceived Efficacy 21 Days of Use at Home - Bepantol Derma Spray® Dermal and Gynecological Acceptability Assessment.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery after a dermatological procedure (peeling) in the intimate area of women. After the peeling, participants will return within 3 weeks for 4 visits to the study center to investigate the skin conditions such redness, irritation, softness and possible side effects. In addition, study participants will be asked about their general acceptance of dexpanthenol dermal spray.
Detailed description
The primary objective is to evaluate the efficacy of the test product to aid skin recovery after peeling in the female intima and inguinal region. Secondary objectives comprise clinical efficacy with respect to skin hydration, softness, vitality, appearance etc. and skin recovery, consumer judgement of product performance and acceptability, and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BAY207543 (Bepanthol, Bepantol® Derma Spray) | Product is applied to one side of the inguinal region. |
| OTHER | Semisolid vaseline | Product is applied to the other side of the inguinal region. |
Timeline
- Start date
- 2019-02-12
- Primary completion
- 2019-03-13
- Completion
- 2019-03-13
- First posted
- 2019-02-25
- Last updated
- 2020-03-11
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03853512. Inclusion in this directory is not an endorsement.